➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Dow
AstraZeneca
Express Scripts
Harvard Business School

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Tetrabenazine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for tetrabenazine and what is the scope of patent protection?

Tetrabenazine is the generic ingredient in two branded drugs marketed by Actavis Labs Fl Inc, Apotex, Bionpharma Inc, Dr Reddys, Hetero Labs Ltd V, Hikma, Lupin Ltd, Mylan, Piramal Hlthcare Uk, Sun Pharm, and Valeant Pharms North, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for tetrabenazine. Twelve suppliers are listed for this compound.

Drug Prices for tetrabenazine

See drug prices for tetrabenazine

Recent Clinical Trials for tetrabenazine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kirk A. FreyPhase 1
Adeptio PharmaceuticalsPhase 1
Dr. Reddy's Laboratories LimitedPhase 1

See all tetrabenazine clinical trials

Pharmacology for tetrabenazine
Medical Subject Heading (MeSH) Categories for tetrabenazine

US Patents and Regulatory Information for tetrabenazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd TETRABENAZINE tetrabenazine TABLET;ORAL 210544-001 Apr 20, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan TETRABENAZINE tetrabenazine TABLET;ORAL 207682-002 Jan 31, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Hikma TETRABENAZINE tetrabenazine TABLET;ORAL 209739-001 Apr 8, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys TETRABENAZINE tetrabenazine TABLET;ORAL 209284-001 Jan 8, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Actavis Labs Fl Inc TETRABENAZINE tetrabenazine TABLET;ORAL 206686-001 Jul 7, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Colorcon
AstraZeneca
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.